Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 2 |
2010 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Novel strategies for patients with chronic myeloproliferative disorders.
Curr Opin Hematol. 2009 Mar;16(2):129-34. doi: 10.1097/MOH.0b013e3283257a9e.
Curr Opin Hematol. 2009.
PMID: 19468275
Free PMC article.
Review.
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents.
Wang X, Zhang W, Ishii T, Sozer S, Wang J, Xu M, Hoffman R.
Wang X, et al.
Cancer Res. 2009 Oct 1;69(19):7612-8. doi: 10.1158/0008-5472.CAN-09-1823. Epub 2009 Sep 14.
Cancer Res. 2009.
PMID: 19752087
Free PMC article.
Item in Clipboard
Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition.
Barosi G, Gattoni E, Guglielmelli P, Campanelli R, Facchetti F, Fisogni S, Goldberg J, Marchioli R, Hoffman R, Vannucchi AM; Myeloproliferative Research Consortium.
Barosi G, et al.
Am J Hematol. 2010 Aug;85(8):616-9. doi: 10.1002/ajh.21754.
Am J Hematol. 2010.
PMID: 20540156
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite